Jasper Therapeutics, Inc. (JSPR) NASDAQ

Currency In USD

Jasper Therapeutics, Inc.

Address

2200 Bridge Pkwy

Redwood City, CA 94065

United States of America (the)

Phone

650 549 1400

Website

https://jaspertherapeutics.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

January 10, 2020

Key Executives

Name	Title	Pay	Year Born
Jeetinder Singh Mahal	President, COO, CEO & Director	610,050	1973
Judith Anne Shizuru	Co-Founder, Member of Scientific Advisory Board & Director	46,300	1957
Thomas G. Wiggans	Executive Chairman	70,000	1952
Herbert C. Cross	Chief Financial Officer & Corporate Secretary	603,925	1972
Luca Di Noto	Senior Vice President of Technical Operations	0	N/A
Daniel C. Adelman	Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor	0	1957
Patricia Carlos	Senior Vice President of Regulatory Affairs & Quality	0	N/A
Alex Gray	Head of Investor Relations	0	N/A
Matthew Ford	Senior Vice President of Human Resources	0	N/A

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for hematopoietic stem cell transplantation and gene therapies. Its core mission is to develop and commercialize conditioning agents and advanced stem cell engineering methods. These advancements aim to expand the utility of stem cell transplantation and ex vivo gene therapy, a process involving genetic modification of cells outside the body before their transplantation. JSP191 stands as the company's leading investigational product, currently in clinical development. This conditioning antibody functions by ablating hematopoietic stem cells from patients' bone marrow as a prerequisite for allogeneic stem cell or stem cell gene therapy. Additionally, Jasper is creating engineered hematopoietic stem cell product candidates intended to address significant limitations inherent in both allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.